Chemical Genomic Approaches to Neurobiology of DISC1

DISC1 神经生物学的化学基因组方法

基本信息

  • 批准号:
    8409821
  • 负责人:
  • 金额:
    $ 65.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2014-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Schizophrenia and bipolar disorder are chronic debilitating disorders that affect 1-3% of the population. The etiology of these disorders is completely unknown. Disrupted in Schizophrenia-1 (DISC1) was identified as the gene that was disrupted on chromosome 1 in a Scottish family with a high concordance of major psychiatric disorders and a balanced translocation between chromosomes 1 and 11. Karyotyping has been done on five generations of this family and 18 of the 29 members with this translocation have schizophrenia, recurrent major depression, or bipolar disorder. This type of near Mendelian segregation for psychiatric disorders indicates an integral role for DISC1 in maintaining mental health and that disruption of DISC1 functions plays a role in the etiology of psychiatric disorders. Indeed, DISC1 mouse models exhibit behavioral abnormalities reminiscent of human disease phenotypes such as hyperlocomotion, increased depressive-like behavior, decreased sociability and working memory. Several of these mouse models also display brain pathology indicative of impairment in brain development. Recently, we reported that DISC1 regulates the proliferation of neural progenitors during embryonic brain development and adult neurogenesis. Furthermore, we discovered that DISC1 regulated neural progenitor proliferation by positively regulating the Wnt signaling pathway by acting as an inhibitor of GSK32, a pleiotropic protein serine/threonine kinase that triggers the degradation of 2-catenin. In the dentate gyrus, DISC1 loss of function causes reduced proliferation of adult neural progenitors, which is accompanied by behavioral consequences including hyperactivity and increased depressive-like behavior. The adult neurogenesis defects and abnormal behavior were reversed upon treatment with a GSK3 chemical inhibitor. Our results indicate that DISC1 plays an important role in controlling GSK32/2-catenin activity, which in turn impacts neurogenesis and psychiatric-related behaviors. In this application, we propose to decipher how DISC1 mutant variants may alter the role of DISC1 in Wnt signaling and neurogenesis. We plan to take a multidisciplinary approach by performing studies with mouse cell and in vivo models, as well as including experiments using human cells to analyze Wnt signaling and neural progenitor development. Furthermore, we will use chemical-genetic approaches to identify and characterize small-molecule probes for conditional and selective modulation of the DISC1/GSK32-Wnt/2-catenin pathway. These studies will ultimately enable a better understanding of the relationship between human genetic variation in DISC1 and the effects on neurogenesis, as well as to lead to a better understanding of the causes and treatment of neuropsychiatric disease.
描述(由申请人提供):精神分裂症和躁郁症是影响1-3%人口的慢性衰弱疾病。这些疾病的病因是完全未知的。精神分裂症1(DISC1)中断为在苏格兰家族中染色体1上断的基因,具有高度精神疾病的一致性,染色体1和11染色体之间的平衡易位。在这个家庭的五代和18个家族中,karyotyping已完成了该家族的五代和易位的疾病,使其具有SCHIZ RENSILIA的29个成员。这种针对精神疾病的近乎孟德尔的隔离表明,Disc1在维持心理健康中的作用不可或缺,而Disc1功能的破坏在精神疾病的病因中起作用。实际上,盘状小鼠模型表现出行为异常,让人联想到人类疾病表型,例如超倒置,增加抑郁样行为,降低社交性和工作记忆。这些小鼠模型中的几个还显示出脑病理学,指示大脑发育障碍。最近,我们报道了DISC1在胚胎脑发育和成人神经发生过程中调节神经祖细胞的增殖。此外,我们发现DISC1通过用作GSK32的抑制剂来调节Wnt信号通路,从而调节神经祖细胞的增殖,GSK32是一种多效性蛋白丝氨酸/苏氨酸激酶,从而触发2-钙蛋白的降解。在齿状回中,椎间盘1的功能丧失导致成人神经祖细胞的增殖减少,伴随着行为后果,包括多动症和抑郁样行为增加。 GSK3化学抑制剂治疗后,成年神经发生缺陷和异常行为逆转。我们的结果表明,Disc1在控制GSK32/2-catenin活性中起着重要作用,这反过来影响神经发生和精神病相关行为。在此应用中,我们建议解释盘1盘突变体的变体如何改变DISC1在Wnt信号传导和神经发生中的作用。我们计划通过对小鼠细胞和体内模型进行研究,以及使用人类细胞分析Wnt信号传导和神经祖细胞发展的实验来采用多学科方法。此外,我们将使用化学遗传学方法来识别和表征小分子探针的条件和选择性调制,以调节盘子1/gsk32-wnt/2-catenin途径。这些研究最终将更好地了解DISC1中人类遗传变异与神经发生的影响之间的关系,并可以更好地了解神经精神疾病的原因和治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Li-Huei Tsai其他文献

Li-Huei Tsai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Li-Huei Tsai', 18)}}的其他基金

Manipulating Neural Oscillations with Non-Invasive Sensory Stimulation for Alzheimer's Disease Intervention
通过非侵入性感觉刺激操纵神经振荡来干预阿尔茨海默病
  • 批准号:
    10378329
  • 财政年份:
    2022
  • 资助金额:
    $ 65.79万
  • 项目类别:
Manipulating Neural Oscillations with Non-Invasive Sensory Stimulation for Alzheimer's Disease Intervention
通过非侵入性感觉刺激操纵神经振荡来干预阿尔茨海默病
  • 批准号:
    10597073
  • 财政年份:
    2022
  • 资助金额:
    $ 65.79万
  • 项目类别:
Noninvasive sensory stimulation to promote glymphatic-lymphatic clearance for the treatment of Alzheimer’s Disease
无创感觉刺激促进类淋巴清除,治疗阿尔茨海默病
  • 批准号:
    10222930
  • 财政年份:
    2021
  • 资助金额:
    $ 65.79万
  • 项目类别:
Noninvasive sensory stimulation to promote glymphatic-lymphatic clearance for the treatment of Alzheimer’s Disease
无创感觉刺激促进类淋巴清除,治疗阿尔茨海默病
  • 批准号:
    10612021
  • 财政年份:
    2021
  • 资助金额:
    $ 65.79万
  • 项目类别:
Noninvasive sensory stimulation to promote glymphatic-lymphatic clearance for the treatment of Alzheimer’s Disease
无创感觉刺激促进类淋巴清除,治疗阿尔茨海默病
  • 批准号:
    10405043
  • 财政年份:
    2021
  • 资助金额:
    $ 65.79万
  • 项目类别:
Manipulating neural oscillations with non-invasive sensory stimulation for Alzheimer's disease intervention
通过非侵入性感觉刺激操纵神经振荡来干预阿尔茨海默病
  • 批准号:
    10228379
  • 财政年份:
    2020
  • 资助金额:
    $ 65.79万
  • 项目类别:
Mechanisms underlying DNA double strand break response in Alzheimer?s disease and frontal temporal dementia
阿尔茨海默病和额颞叶痴呆中 DNA 双链断裂反应的机制
  • 批准号:
    10210448
  • 财政年份:
    2017
  • 资助金额:
    $ 65.79万
  • 项目类别:
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease
针对大脑衰老和阿尔茨海默病的新型调节剂
  • 批准号:
    9321469
  • 财政年份:
    2014
  • 资助金额:
    $ 65.79万
  • 项目类别:
Examination of neural circuits underlying mood disorders in Alzheimer?s disease
阿尔茨海默病情绪障碍的神经回路检查
  • 批准号:
    8711599
  • 财政年份:
    2014
  • 资助金额:
    $ 65.79万
  • 项目类别:
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease
针对大脑衰老和阿尔茨海默病的新型调节剂
  • 批准号:
    8921933
  • 财政年份:
    2014
  • 资助金额:
    $ 65.79万
  • 项目类别:

相似国自然基金

KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
  • 批准号:
    82200258
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
  • 批准号:
    82171845
  • 批准年份:
    2021
  • 资助金额:
    54.00 万元
  • 项目类别:
    面上项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
全基因组范围内揭示杂交肉兔等位基因特异性表达模式对杂种优势遗传基础的影响
  • 批准号:
    32102530
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
  • 批准号:
    10752274
  • 财政年份:
    2024
  • 资助金额:
    $ 65.79万
  • 项目类别:
Generation of a new Cre-deleter mouse line to study spermiogenesis
生成新的 Cre-deleter 小鼠品系以研究精子发生
  • 批准号:
    10668012
  • 财政年份:
    2023
  • 资助金额:
    $ 65.79万
  • 项目类别:
In vivo precision genome editing to correct genetic disease
体内精准基因组编辑以纠正遗传疾病
  • 批准号:
    10771419
  • 财政年份:
    2023
  • 资助金额:
    $ 65.79万
  • 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
  • 批准号:
    10817516
  • 财政年份:
    2023
  • 资助金额:
    $ 65.79万
  • 项目类别:
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
  • 批准号:
    10709381
  • 财政年份:
    2023
  • 资助金额:
    $ 65.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了